Navigation Links
At 30, biotech is an industry at a crossroads

So just how old is the biotech industry? The July 2006 edition of MedAd News sustains that the industry has hit its 30th birthday this year. On Aug, 23, 2004, I wrote an article for this publication on "The Birth of Biotech: San Francisco, Boston, Geneva, or Chicago?"

In this ar......

Full article >>> llion, which grew 18 percent over the prior year (remember that the entire pharmaceutical industry grew 7 percent last year, and 5 percent in North America).
  • Losses of $4.3 billion, which decreased 30 percent from the prior year.
  • 32 new product approvals in the U.S., including 17 first-time approvals.
  • The second highest year for raising capital......

    Full article >>> companies.
  • Focus of cancer drugs on tumor types rather than tumor location: This dynamic is changing treatment modality in oncology. There are over 400 cancer drugs in development, and this development is changing how oncology clinical trials are being conducted. For example, it is not enough to say a patient has lung cancer today, as there are two broad types of lung can......

    Full article >>> nentech (U.S. - 1976)$6,633+44%$1,279+63%3. Genzyme (U.S. - 1981 )$2,735+24%$442+408%4. Serono (Switzerland - 1906 )**$2,586+5%<$105>N/A5. CSL (Australia - 1961)**$2,494+77%$419+149%6.......

    Full article >>> td>+49%22.Enzon Pharmaceuticals (U.S. - 1981)$166<2%><$90>N/A23.Vertex Pharmaceuticals (U.S. - 1989)$161+56%<$203><22%>24.Amylin Pharmaceuticals (U.S. - 1987)$141+315%<$207><32%>25.Berna Biotech (Switzerland - 1898)**
    Full article >>> 006

    Clearly, Amgen and Genentech are spending prodigious R&D sums, comparable to Big Pharma levels, but the next 3 yo 4 companies are not too far behind. This R&D is the life blood of a biotech company.

    All of the above trends noted by MedAd News really only focus on the drug part of biotech. As a result, I would add the following trends:



    Source:wistechnology.com By Michael Rosen 08/01/06


    Related biology technology :

    1. The state of global biotech: An Ernst & Young perspective
    2. Olympics of biotechnology has international flavor
    3. Getting noticed in Genetown: Wisconsin biotech on display
    4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
    5. Wisconsin biotech firm receives $107K NIH grant
    6. Manufacturing partnership will move into biotech and biomedical spaces
    7. Wisconsin wont get Georgia biotech without a fight
    8. The 10 biggest events shaping biotech in 2006
    9. NimbleGen partners with UK biotech firm
    10. 2006: A great biotech financing year, unless you were going public!
    11. Big pharma seeks Wisconsin biotech partnerships
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
    (Date:3/22/2017)... 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
    (Date:3/22/2017)... --  iSpecimen ®, the marketplace for human ... (DPS), a full-service anatomic pathology reference lab serving ... , has joined a program offered by iSpecimen ... to make human biospecimens and associated data available to ... in 2015 as a collaboration between iSpecimen and DHIN, ...
    (Date:3/22/2017)... Mass. , March 22, 2017   Boston ... next-generation cancer therapeutics designed to target cancer stemness pathways, ... Patricia S. Andrews as Chief Executive Officer, effective ... succeed Chiang J. Li , M.D., FACP, who ... ten years ago. Under his leadership, Boston Biomedical has ...
    Breaking Biology Technology:
    (Date:3/1/2017)... 2017  Aware, Inc. (NASDAQ: AWRE), a leading supplier ... P. Moberg has resigned, effective March 3, 2017, ... Officer and Treasurer of Aware citing a desire to ... member of the Board of Directors of Aware. ... Officer and co-President, General Counsel has been named Chief ...
    (Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
    (Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
    Breaking Biology News(10 mins):